 Connection
Robert Fuhlbrigge to Neoplasms
This is a "connection" page, showing publications Robert Fuhlbrigge has written about Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.130 |
|
|
|
-
Tian T, Lofftus S, Pan Y, Stingley CA, King SL, Zhao J, Pan TY, Lock R, Marglous JW, Liu K, Widlund HR, Fuhlbrigge RC, Cichowski K, Kupper TS. IL1a Antagonizes IL1? and Promotes Adaptive Immune Rejection of Malignant Tumors. Cancer Immunol Res. 2020 05; 8(5):660-671.
Score: 0.067
-
Aires DJ, Yoshida M, Richardson SK, Bai M, Liu L, Moreno R, Lazar AJF, Wick JA, Rich BE, Murphy G, Blumberg RS, Fuhlbrigge RC, Kupper TS. T-cell trafficking plays an essential role in tumor immunity. Lab Invest. 2019 01; 99(1):85-92.
Score: 0.061
-
Edwards BS, Merritt JA, Fuhlbrigge RC, Borden EC. Low doses of interferon alpha result in more effective clinical natural killer cell activation. J Clin Invest. 1985 Jun; 75(6):1908-13.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|